Do I Need Testosterone in Menopause? What the Science Actually Says

Why does testosterone matter during menopause?

Testosterone is not just a male hormone. Women produce it in the ovaries and adrenal glands, where it plays supporting roles in libido, energy, muscle maintenance, bone density, and mood. The body also makes testosterone from DHEA (dehydroepiandrosterone), a precursor hormone produced in the adrenal glands that converts into both estrogen and testosterone depending on what the body needs at a given moment.

Unlike estrogen, testosterone does not drop sharply at menopause. Instead, levels decline gradually from the early 30s onward as the ovaries slowly reduce output over decades. By the time perimenopause arrives, many women have already lost half or more of their peak testosterone - but because that decline was slow and incremental, the body has adjusted over time rather than all at once.

The sharp estrogen drop of perimenopause, which what really happens in menopause covers in biological detail, is a much more abrupt event with more immediate and dramatic consequences for symptoms. Testosterone still matters in midlife. But its story is different from estrogen's, and conflating the two leads to treatments that miss the actual driver.

How does testosterone actually change in perimenopause?

The popular narrative holds that menopause drains testosterone and that restoring it solves a cluster of symptoms. The data is more complicated. A 2026 analysis from the Australian Women's Midlife Years Study (Wang and colleagues, Fertility and Sterility, 2026) followed 731 peri- and post-menopausal women and found no significant association between any measured androgen level - including total testosterone - and sexual desire, after adjusting for age, BMI, relationship status, education, and other relevant factors.

That finding has a direct practical implication: ordering a testosterone blood test and using the result to explain low libido does not reliably work. Two women with identical testosterone readings can have completely different experiences of desire. A hormone number on a lab report is one data point in a much larger picture, not a diagnosis.

Testosterone functions within an interacting system of hormones, neurotransmitters, and lifestyle factors. What is driving symptoms may be estrogen, sleep disruption, thyroid function, medication side effects, or chronic stress - not testosterone acting alone or even primarily.

What does the research actually support for testosterone therapy?

The clearest and most consistent evidence for testosterone therapy in women addresses one specific condition: Hypoactive Sexual Desire Disorder, or HSDD. HSDD is defined as persistently low or absent sexual desire causing genuine personal distress, where relationship conflict, depression, medication side effects, or another medical condition has been ruled out as the primary cause. The distress component matters - if lower desire does not bother you, HSDD does not apply.

The International Society for the Study of Women's Sexual Health clinical practice guideline (Parish and colleagues, Journal of Sexual Medicine, 2021) reviewed the full evidence base and recommends transdermal testosterone for post-menopausal women with confirmed HSDD. The guideline also makes a point worth noting: blood testosterone levels should not be the primary diagnostic criterion. The diagnosis rests on the symptom itself and its impact on the person's life - not a lab value.

Critically, the guideline does not extend that recommendation to energy, mood, cognitive function, or weight. Those are not areas where the current evidence supports routine testosterone prescribing, regardless of how compelling the logic sounds.

What about DHEA, the testosterone precursor?

DHEA (dehydroepiandrosterone) is produced in the adrenal glands and converted by the body into both estrogen and testosterone. Because of that conversion pathway, DHEA supplements are frequently marketed as a natural route to raising testosterone and easing a wide range of menopause symptoms - everything from low libido to fatigue to brain fog.

A 2022 review in the Journal of Clinical Endocrinology and Metabolism (Wierman and Kiseljak-Vassiliades, 2022) examined the full published evidence on DHEA in women and reached a clear conclusion: for healthy menopausal women without adrenal insufficiency, oral DHEA supplementation has shown no consistent beneficial effects on menopausal symptoms, sexual function, cognition, or overall wellbeing.

Where DHEA does have evidence is in one specific, localized form - intravaginal DHEA (prasterone), prescribed for vaginal dryness and pain with intercourse. That is a narrow topical use case and should not be used to justify oral DHEA as a broad menopause remedy.

Being a biochemical precursor to testosterone does not mean oral DHEA reliably raises testosterone to a therapeutically meaningful level. The conversion depends on tissue-specific enzymes and varies significantly between individuals. The supplement often does not produce the same effect as the hormone itself, taken directly.

Why does menopause fatigue get blamed on testosterone?

Fatigue is one of the most common and disruptive menopause symptoms, and because testosterone supports energy in general physiology, the idea that low testosterone explains menopause exhaustion feels logical. The clinical evidence points in a different direction.

Menopause fatigue is primarily driven by disrupted sleep from night sweats and changing brain chemistry, by falling estrogen affecting mitochondrial energy production at the cellular level, and by a cortisol system that becomes louder - more reactive to everyday stress - at exactly the time when other hormones are no longer there to moderate it. That cortisol amplification, rather than a testosterone deficit, is usually the engine behind the crash. The article on what actually helps menopause fatigue explores these drivers in detail, and brain fog in menopause covers the cognitive side of the same hormonal transition.

Testosterone therapy has not been shown to reliably improve energy or reduce fatigue in menopausal women who do not have HSDD. If fatigue is the primary complaint, the more productive starting point is sleep quality, cortisol patterns, and nutritional deficiencies - not testosterone.

When is testosterone worth a conversation with your doctor?

There is a specific clinical profile where raising testosterone with a specialist is genuinely appropriate. Libido has not merely dipped - it has dropped substantially or disappeared, and that loss is causing real personal distress. Estrogen and progesterone levels have been assessed and any corrections made without restoring desire. Other causes - antidepressants, relationship strain, depression, thyroid dysfunction, low iron - have been considered and are not the primary driver.

That is the profile the ISSWSH guideline describes. In that situation, a specialist-level conversation about transdermal testosterone is reasonable. Treatment success is evaluated based on whether the symptom actually improves for the individual - not whether a lab number reaches a particular target.

A useful first step before that conversation is understanding the full hormonal picture, particularly progesterone. Progesterone is often the first hormone to decline in perimenopause, reshaping sleep and mood for years before estrogen makes its more dramatic exit. Addressing progesterone sometimes changes the desire picture on its own, without adding testosterone.

What supports healthy androgen levels without a prescription?

The evidence for lifestyle approaches to testosterone in women is narrower than the supplement marketing suggests, but a few things have genuine support.

Resistance training is the most consistently backed approach. Strength work recruits the androgen system, preserves muscle mass that testosterone helps maintain, and produces real improvements in energy and body composition - effects that are often wrongly attributed to "needing testosterone" when they are actually achievable through training. Adequate sleep matters because testosterone and androgen production happen primarily overnight, and the sleep disruption that comes with menopause compounds this at a time when other hormonal buffers are already reduced.

Reducing alcohol consumption and managing chronic stress are also relevant because cortisol and androgens compete for shared biosynthetic precursors. Chronically elevated cortisol - a pattern common in midlife women under sustained pressure - can suppress androgen production over time. Zinc and vitamin D support androgen pathways and are worth checking through a blood panel if deficiency is possible, particularly if diet or sun exposure may have left levels low. Supplementing when levels are already adequate does not appear to raise testosterone further in healthy women.

My Perspective

The testosterone conversation in menopause is one of those areas where social media has moved well ahead of the research. The popular version holds that any woman over 45 who feels tired, foggy, or uninterested in sex should be on testosterone, and that clinicians who decline to prescribe it are simply behind the times.

What the research actually shows is more specific and more interesting than that framing. The evidence supports testosterone for one clearly defined complaint - sexual desire so low it causes genuine distress - and not as a remedy for the broader range of things that unravel in perimenopause. The 2026 study finding no consistent link between measured testosterone levels and sexual desire in over 700 midlife women is a significant corrective to a lot of online certainty. The blood test number is not the story. The symptom, and whether it is actually disrupting your life, is the story.

If libido has genuinely disappeared and everything else has been considered, testosterone is a reasonable thing to explore with a clinician who specializes in this area. If the complaint is primarily fatigue or brain fog, chasing testosterone is almost certainly chasing the wrong hormone. The hormonal story of perimenopause starts with progesterone sliding away quietly, then estrogen making its dramatic exit, while cortisol gets louder throughout. Testosterone is a real player - but it tends to be miscast as the lead when it is really in a supporting role.

The Estrogen Left the Chat: Biohacking Menopause framework is built around exactly this kind of specificity - identifying which signal is actually off before reaching for an intervention. If you want to bring a clear, timestamped symptom picture to that clinical conversation, Receipts is built to help you track what is happening, when, and how much it is affecting you.

A note from Marilyn: This article is education, not medical advice or a treatment recommendation. Testosterone therapy requires proper clinical evaluation and takes into account your individual health history, other medications, and your complete hormonal picture. Please work with your own healthcare provider before making any decisions about hormone treatment. I am a nutrition specialist, not your physician.